Comparative evaluation of a triplex nucleic acid test for detection of HBV DNA, HCV RNA, and HIV-1 RNA, with the Procleix Tigris System

Journal of Virological Methods

Volumn 187, Issue 2, 2013, Pages 357-361

  Xiao, Xinglong ^a   Zhai, Jianxin ^b   Zeng, Jinfeng ^c   Tian, Cong ^a   Wu, Hui ^a   Yu, Yigang ^a  

^a SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

^b Taitaigen Inc   (China)

^c E mail: szbloodcenter hotmailcom   (China)

Author keywords

Clinical evaluation; Hepatitis B virus; NAT; Occult infection; Transfusion

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; NUCLEIC ACID; VIRUS DNA; VIRUS RNA;

ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPING TECHNIQUE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERMETHOD COMPARISON; MEDICAL PROCEDURES; NONHUMAN; PRIORITY JOURNAL; PROCESS DEVELOPMENT; SCREENING TEST; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SERODIAGNOSIS; TRIPLEX NUCLEIC ACID TEST; VIRUS GENOME; VIRUS IDENTIFICATION; VIRUS LOAD;

CHINA; DNA, VIRAL; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIROLOGY;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84872676079     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2012.10.015     Document Type: Article

References (15)

1. Allain J.-P. Occult hepatitis B virus infection. Transfus. Clin. Biol. 2004, 11:18-25.
2. Assal A., Barlet V., Deschaseaux M., Dupont I., Gallian P., Guitton C., et al. Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 201. Transfusion (Paris) 2009, 49:289-300.
3. Assal A., Barlet V., Deschaseaux M., Dupont I., Gallian P., Guitton C., et al. Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels. Transfusion (Paris) 2009, 49:301-310.
4. Gong X.Y., Ren F.R., Song M.L., Wang Z.Y., Yao F.L., Zhu J.M. Comparison of mini-pool NAT and individual donor NAT for blood donation screening on Roche cobas s 201. Chin. J. Blood Transfus 2010, 23:162. (in Chinese).
5. Jarvis L., Becker J., Tender A., Cleland A., Queiros L., Aquiar A., et al. Evaluation of the Roche cobas s 201 system and cobas TaqScreen multiplex test for blood screening: a European multicenter study. Transfusion (Paris) 2008, 48:1853-1861.
6. Kuhns M.C., Kleinman S.H., McNamara A.L., Rawal B., Glynn S., Busch M.P. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Transfusion (Paris) 2004, 44:1332-1339.
7. Lebedev A.V., Paul N., Yee J., Timoshchuk V.A., Shum J., Miyagi K., et al. Hot Start PCR with heat-activatable primers: a novel approach for improved PCR performance. Nucleic Acids Res. 2008, 36:e131.
8. Li L., Chen P.J., Chen M.H., Chak K.F., Lin K.S., Tsai S.-J.L. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus. Transfusion (Paris) 2008, 48:1198-1206.
9. Liu C.J., Chen D.S., Chen P.J. Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT. J. Clin. Virol. 2006, 36:S33-S44.
10. Liu C.J., Lo S.C., Kao J.H., Tseng P.T., Lai M.Y., Ni Y.H., et al. Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan. J. Hepatol. 2006, 44:39-46.
11. Margaritis A.R., Brown S.M., Seed C.R., Kiely P., D'Agostino B., Keller A.J. Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA. Transfusion (Paris) 2007, 47:1783-1793.
12. McCormick M.K., Dockter J., Linnen J.M., Kolk D., Wu Y., Giachetti C. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA. J. Clin. Virol. 2006, 36:166-176.
13. Ohhashi Y., Pai A., Halait H., Ziermann R. Analytical and clinical performance evaluation of the cobas TaqScreen MPX test for use on the cobas s 201 system. J. Virol. Methods 2010, 165:246-253.
14. Schmidt M., Pichl L., Jork C., Hourfar M.K., Schottstedt V., Wagner F.F., et al. Blood donor screening with cobas s 201/cobas TaqScreen MPX under routine conditions at German Red Cross Institutes. Vox Sang. 2010, 98:37-46.
15. Song M.L., Ren F.R., Gong X.Y., Yao F.L., Wang Z.Y., Zhu J.M. Comparative clinical evaluation of mini-pool NAT and individual donor NAT by PROCLEIX ULTRIO assay for donation screening. Chin. J. Blood Transfus. 2010, 23:173. (in Chinese).